Sfoglia per Autore
HCV clearance among hemophiliacs and beta-thalassemics
2007-01-01 DI MARCO V; BRONTE F; SICILY GROUP FOR THE STUDY OF THALASSEMIA; CAPRA M; GERARDI; C; MAGGIO A; MALIZIA R; RIZZO M
STAGING OF FIBROSIS BY LIVER STIFFNESS MEASUREMENT IN THALASSEMICS WITH IRON OVERLOAD
2007-01-01 V DI MARCO; F BRONTE; CABIBI D; F; BARBARIA; Z BORSELLINO; G ALAIMO; S CIMINNISI; M CAPRA; A MAGGIO; PL ALMASIO; A CRAXI
Liver disease in chelated transfusion-dependent thalassemics: the role of iron and chronic hepatitis C
2008-01-01 DI MARCO V; CAPRA M; GAGLIARDOTTO F; BORSELLINO Z; CABIBI D; BARBARIA F; FERRARO D; CUCCIA L; RUFFO GB; BRONTE F; DI STEFANO R; ALMASIO PL; CRAXÌ A
Liver disease in chelated transfusion-dependent thalassemics: the role of iron overload and chronic hepatitis C.
2008-01-01 DI MARCO, V; CAPRA, M; GAGLIARDOTTO, F; BORSELLINO, Z; CABIBI, D; BARBARIA, F; FERRARO, D; CUCCIA, L; RUFFO, GB; BRONTE, F; DI STEFANO, R; ALMASIO, PL; CRAXI', A
Insulin resistance is a risk factor for esophageal varices in hepatitis C virus cirrhosis.
2009-01-01 CAMMÀ C; PETTA S; DI MARCO V; BRONTE F; CIMINNISI S; LICATA G; PERALTA S; SIMONE F; MARCHESINI G; CRAXI' A
Retreatment with pegylated interferon plus ribavirin of chronic hepatitis C non-responders to interferon plus ribavirin: A meta-analysis.
2009-01-01 Cammà, C; Cabibbo, G; Bronte, F; Enea, M; Licata, A; Attanasio, M; Andriulli, A; Craxi, A
Noninvasive assessment of liver fibrosis in thalassaemia major patients by transient elastography (TE) - lack of interference by iron deposition.
2009-01-01 Di Marco, V; Bronte, F; Cabibi, D; Calvaruso, V; Alaimo, G; Borsellino, Z; Gagliardotto, F; Almasio, PL; Capra, M; Craxì, A
Insulin resistance is a major determinant of liver stiffness in nondiabetic patients with HCV genotype 1 chronic hepatitis
2009-01-01 Petta, S; Cammà, C; DI Marco, V; Calvaruso, V; Enea, M; Bronte, F; Butera, G; Cabibi, D; Craxì, A.
Fibrosis staging in chronic hepatitis C: analysis of discordance between transient elastography and liver biopsy
2009-01-01 Calvaruso, V; Cammà, C; Di Marco, V; Maimone, S; Bronte, F; Enea, M; Dardanoni, V; Manousou, P; Pleguezuelo, M; Xirouchakis, E; Attanasio, M; Dusheiko, G; Burroughs, AK; Craxì A
Liver stiffness measurement by transient elastography predicts early recovery from acute hepatitis
2011-01-01 Di Marco, V; Calvaruso, V; Iacò, A; Bronte, F; Biasi, L; Prestini, K; Sacchi, P; Amaddeo, G; Squadrito, G; Bruno, R; Puoti, M; Craxi, A
Comparison of transient elastography and acoustic radiation force impulse for non-invasive staging of liver fibrosis in patients with chronic hepatitis C.
2011-01-01 Rizzo, L; Calvaruso, V; Cacopardo, B; Alessi, N; Attanasio, M; Petta, S; Fatuzzo, F; Montineri, A; Mazzola, A; L'abbate, L; Nunnari, G; Bronte, F; Di Marco, V; Craxì, A; Cammà, C.
IL28B polymorphisms influence stage of fibrosis and spontaneous or interferon-induced viral clearance in thalassemia patients with hepatitis C virus infection.
2012-01-01 Di Marco, V; Bronte, F; Calvaruso, V; Capra, M; Borsellino, Z; Maggio, A; Renda, MC; Pitrolo, L; Lo Pinto, MC; Rizzo, M; Fiorenza, F; Gerardi, C; Grimaudo, S; Di Cristina, A; Levrero, M; Craxi, A
Cost-Effectiveness of Boceprevir or Telaprevir for Untreated Patients with Genotype 1 Chronic Hepatitis C
2012-01-01 Cammà, C; Petta, S; Enea, M; Bruno, R; Bronte, F; Capursi, V; Cicchetti, A; Colombo, GL; Di Marco, V; Gasbarrini, A; Craxì, A
HBsAg quantification in HBeAg negative cirrhosis on nucleoside/nucleotide analogue (NA) and risk of development of HCC
2013-01-01 Bronte, F.; Ferraro, D.; Calvaruso, V.; Pecoraro, G.; Sferrazza, S.; Augugliaro, M.; Destri, N.; Craxi, A.; DI MARCO, V.
Modified spleen stiffness measurement by transient elastography is associated with presence of large oesophageal varices in patients with compensated hepatitis C virus cirrhosis
2013-01-01 Calvaruso, V.; Bronte, F.; Conte, E.; Simone, F.; Craxi, A.; Di Marco, V.
The risk of hepatocellular carcinoma in HBV cirrhosis is affected by polymorphisms of the MERTK gene
2014-01-01 Bronte, F.; Pipitone, R.; Grimaudo, S.; Ferraro, D.; Calvaruso, V.; Sferrazza, S.; Pecoraro, G.; Augugliaro, M.; Craxi, A.; DI MARCO, V.
Targeted Therapies in Hepatocellular Carcinoma
2014-01-01 Bronte, F.; Bronte, G.; Cusenza, S.; Fiorentino, E.; Rolfo, C.; Cicero, G.; Bronte, E.; DI MARCO, V.; Firenze, A.; Angarano, G.; Fontana, T.; Russo, A.
Quantification of fibrosis by collagen proportionate area predicts hepatic decompensation in hepatitis C cirrhosis
2015-01-01 Calvaruso V, Di Marco V, Bavetta MG, Cabibi D, Conte E, Bronte F, Simone F, Burroughs AK, Craxì A.
What links BRAF to the heart function? New insights from the cardiotoxicity of BRAF inhibitors in cancer treatment
2015-01-01 Bronte, E.; Bronte, G.; Novo, G.; Bronte, F.; Bavetta, M.; Re, G.; Brancatelli, G.; Bazan, V.; Natoli, C.; Novo, S.; Russo, A.
Comparison of Histochemical Stainings in Evaluation of Liver Fibrosis and Correlation with Transient Elastography in Chronic Hepatitis
2015-01-01 Cabibi, D.; Bronte, F.; Porcasi, R.; Ingrao, S.; Giannone, A.; Maida, M.; Grazia Bavetta, M.; Petta, S.; Di Marco, V.; Calvaruso, V.
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile